<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T03:30:47Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6860403" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6860403</identifier>
        <datestamp>2019-12-03</datestamp>
        <setSpec>bmjgroup</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="brief-report">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Med Genet</journal-id>
              <journal-id journal-id-type="iso-abbrev">J. Med. Genet</journal-id>
              <journal-id journal-id-type="hwp">jmedgenet</journal-id>
              <journal-id journal-id-type="publisher-id">jmg</journal-id>
              <journal-title-group>
                <journal-title>Journal of Medical Genetics</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0022-2593</issn>
              <issn pub-type="epub">1468-6244</issn>
              <publisher>
                <publisher-name>BMJ Publishing Group</publisher-name>
                <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6860403</article-id>
              <article-id pub-id-type="pmcid">PMC6860403</article-id>
              <article-id pub-id-type="pmc-uid">6860403</article-id>
              <article-id pub-id-type="pmid">30385646</article-id>
              <article-id pub-id-type="pmid">30385646</article-id>
              <article-id pub-id-type="publisher-id">jmedgenet-2018-105560</article-id>
              <article-id pub-id-type="doi">10.1136/jmedgenet-2018-105560</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Phenotypes</subject>
                </subj-group>
                <subj-group subj-group-type="hwp-journal-coll">
                  <subject>1506</subject>
                </subj-group>
                <series-title>Short report</series-title>
              </article-categories>
              <title-group>
                <article-title>Expanding the phenotype of COPA syndrome: a kindred with typical and atypical features</article-title>
              </title-group>
              <contrib-group>
                <contrib id="author-63394707" contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Taveira-DaSilva</surname>
                    <given-names>Angelo M</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib id="author-23828967" contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Markello</surname>
                    <given-names>Thomas C</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">2</xref>
                </contrib>
                <contrib id="author-63394762" contrib-type="author">
                  <name>
                    <surname>Kleiner</surname>
                    <given-names>David E</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">3</xref>
                </contrib>
                <contrib id="author-63394780" contrib-type="author">
                  <name>
                    <surname>Jones</surname>
                    <given-names>Amanda M</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib id="author-63394793" contrib-type="author">
                  <name>
                    <surname>Groden</surname>
                    <given-names>Catherine</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">2</xref>
                </contrib>
                <contrib id="author-63394800" contrib-type="author">
                  <name>
                    <surname>Macnamara</surname>
                    <given-names>Ellen</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">2</xref>
                </contrib>
                <contrib id="author-63394817" contrib-type="author">
                  <name>
                    <surname>Yokoyama</surname>
                    <given-names>Tadafumi</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff4">4</xref>
                </contrib>
                <contrib id="author-27272434" contrib-type="author">
                  <name>
                    <surname>Gahl</surname>
                    <given-names>William A</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">2</xref>
                  <xref ref-type="aff" rid="aff4">4</xref>
                </contrib>
                <contrib id="author-63394062" contrib-type="author" equal-contrib="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4727-8918</contrib-id>
                  <name>
                    <surname>Gochuico</surname>
                    <given-names>Bernadette R</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff4">4</xref>
                </contrib>
                <contrib id="author-63394843" contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Moss</surname>
                    <given-names>Joel</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
              </contrib-group>
              <aff id="aff1"><label>1</label><institution content-type="department">Pulmonary Branch</institution>, <institution>National Heart, Lung, and Blood Institute, National Institutes of Health</institution>, <addr-line content-type="city">Bethesda</addr-line>, <addr-line content-type="state">Maryland</addr-line>, <country>USA</country></aff>
              <aff id="aff2"><label>2</label><institution>NIH Undiagnosed Diseases Program</institution>, <addr-line content-type="city">Bethesda</addr-line>, <addr-line content-type="state">Maryland</addr-line>, <country>USA</country></aff>
              <aff id="aff3"><label>3</label><institution>Center for Cancer Research, National Cancer Institute</institution>, <addr-line content-type="city">Bethesda</addr-line>, <addr-line content-type="state">Maryland</addr-line>, <country>USA</country></aff>
              <aff id="aff4"><label>4</label><institution content-type="department">Medical Genetics Branch</institution>, <institution>National Human Genome Research Institute</institution>, <addr-line content-type="city">Bethesda</addr-line>, <addr-line content-type="state">Maryland</addr-line>, <country>USA</country></aff>
              <author-notes>
                <corresp><label>Correspondence to</label> Dr Bernadette R Gochuico, Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892-1851, USA; <email>gochuicb@mail.nih.gov</email></corresp>
              </author-notes>
              <pub-date pub-type="ppub">
                <month>11</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>1</day>
                <month>11</month>
                <year>2018</year>
              </pub-date>
              <volume>56</volume>
              <issue>11</issue>
              <fpage>778</fpage>
              <lpage>782</lpage>
              <history>
                <date date-type="received">
                  <day>20</day>
                  <month>7</month>
                  <year>2018</year>
                </date>
                <date date-type="rev-recd">
                  <day>14</day>
                  <month>9</month>
                  <year>2018</year>
                </date>
                <date date-type="accepted">
                  <day>30</day>
                  <month>9</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license license-type="open-access">
                  <license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <self-uri xlink:title="pdf" xlink:href="jmedgenet-2018-105560.pdf"/>
              <abstract>
                <sec>
                  <title>Background</title>
                  <p>Copa syndrome is a rare autosomal dominant disorder with abnormal intracellular vesicle trafficking. The objective of this work is to expand the knowledge about this disorder by delineating phenotypic features of an unreported COPA family.</p>
                </sec>
                <sec>
                  <title>Methods and results</title>
                  <p>A heterozygous missense variant (c.698 G&gt;A, p.Arg233His) in <italic>COPA</italic> was identified in four members of a three-generation kindred with lung, autoimmune and malignant disease of unknown aetiology. Ages of onset were 56, 26, 16 and 1 year, with earlier age of onset in successive generations. Presenting symptoms were cough and dyspnoea. Findings included small lung cysts, follicular bronchiolitis, interstitial lung disease, neuroendocrine cell hyperplasia, rheumatoid arthritis, avascular necrosis and select abnormal autoimmune serologies. Neither alveolar haemorrhage nor glomerular disease were present. Features not previously associated with Copa syndrome included neuromyelitis optica, pulmonary carcinoid tumour, clear cell renal carcinoma, renal cysts, hepatic cysts, nephrolithiasis, pyelonephritis and meningitis. Longitudinal evaluations demonstrated slow progression of lung disease and extrapulmonary cysts.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p>Worsening severity with successive generations may be observed in Copa syndrome. Extrapulmonary cysts, malignancies, autoimmune neurological disorders and infections are clinical features that may be associated with Copa syndrome. Further studies are indicated to fully define the phenotypic spectrum of this disorder.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>arthritis</kwd>
                <kwd>follicular bronchiolitis</kwd>
                <kwd>lung cysts</kwd>
                <kwd>neuromyelitis optica</kwd>
                <kwd>renal cell carcinoma</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-1">
                  <funding-source>
                    <institution-wrap>
                      <institution>Intramural Research Programs of the National Heart, Lung and Blood Institute, the Office of the Director, the National Cancer Institute, and the National Human Genome Research Institute, National Institutes of Health</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>special-feature</meta-name>
                  <meta-value>unlocked</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="s1">
              <title>Introduction</title>
              <p>Copa syndrome (MIM: 616414) is a multisystemic autosomal dominant disorder with incomplete penetrance characterised by dysfunctional cellular trafficking; it primarily involves the lungs, kidneys and joints.<xref rid="R1" ref-type="bibr">1</xref> Alveolar haemorrhage, a major pulmonary feature of Copa syndrome, is associated with interstitial lung disease, follicular bronchiolitis and lung cysts.<xref rid="R2" ref-type="bibr">2</xref> Renal involvement includes glomerular disease with or without immune complex deposition. Proteinuria and reduced renal function have been observed.<xref rid="R3" ref-type="bibr">3</xref> Humoral autoimmunity and inflammatory polyarticular arthritis involving the knees and small joint of the hands are other manifestations.<xref rid="R1" ref-type="bibr">1 3</xref> Most previously described patients presented before the sixth year of life. Patients are generally treated with immunosuppressants; some with severe pulmonary disease underwent lung transplantation.<xref rid="R2" ref-type="bibr">2–4</xref>
</p>
              <p><italic>COPA</italic> encodes the alpha subunit of coatomer complex-I (COPI), which functions in the retrograde trafficking of proteins from the Golgi to the endoplasmic reticulum (ER).<xref rid="R5" ref-type="bibr">5 6</xref> Nine previous kindreds have been reported with missense variants mapping to the WD40 domain of the COPA protein, along with two other reports.<xref rid="R1" ref-type="bibr">1 7 8</xref> Four <italic>COPA</italic> variants in this highly conserved region are predicted to be deleterious.<xref rid="R1" ref-type="bibr">1</xref> Investigations into pathogenesis of disease showed cellular dysfunction with normal levels of <italic>COPA</italic> transcript and COPA protein in cells from patients with Copa syndrome.<xref rid="R1" ref-type="bibr">1</xref>
</p>
              <p>We report two male and two female patients in a new kindred with Copa syndrome and show earlier age of onset of symptomatic lung disease in three successive generations. Exome analysis identified a missense variant in the <italic>COPA</italic> WD40 domain. In addition, there are atypical manifestations in these four affected patients. The clinical presentation and natural history for this kindred expand the phenotype of Copa syndrome.</p>
            </sec>
            <sec id="s2">
              <title>Materials and methods</title>
              <sec id="s2a">
                <title>Patient consent and ethics approval</title>
                <p>Written informed consent was obtained. Patients were enrolled in clinical protocols 95 H-0186 (Clinical Trials NCT00001465), 96 H-0100 (Clinical Trials NCT00001532) and/or 76-HG-0238 (Clinical Trials NCT00369421). The patients were enrolled in the National Institute of Health (NIH) Undiagnosed Diseases Programme.<xref rid="R9" ref-type="bibr">9–11</xref> Clinical evaluations were performed at the NIH Clinical Centre in Bethesda, Maryland, USA.</p>
              </sec>
              <sec id="s2b">
                <title>Pulmonary function testing</title>
                <p>Forced vital capacity, forced expiratory volume in 1 s, total lung capacity and diffusion capacity were measured (Vmax Encore, Vyaire Medical, Yorba Linda, California, USA).<xref rid="R12" ref-type="bibr">12</xref>
</p>
              </sec>
              <sec id="s2c">
                <title>Clinical imaging</title>
                <p>Conventional and high-resolution chest CT scans, abdominal CT scans and abdominal and brain MRI were performed.<xref rid="R13" ref-type="bibr">13–15</xref>
</p>
              </sec>
              <sec id="s2d">
                <title>Histopathology</title>
                <p>Tissue specimens from the proband and her father were obtained by clinically indicated open lung biopsies. Kidney tissue from the proband’s father was procured from his clinically indicated renal mass resection. Sections were stained with H&amp;E; immunohistochemistry for synaptophysin was performed on lung tissue from the proband’s father.</p>
              </sec>
              <sec id="s2e">
                <title>Genetic analysis</title>
                <p>Genomic DNA was isolated from peripheral blood of family members evaluated at the initial NIH admission. Three affected adult patients and the unaffected proband’s mother were analysed by whole exome sequencing.<xref rid="R16" ref-type="bibr">16</xref> A heterozygous variant (c.698 G&gt;A, p.Arg233His) in <italic>COPA</italic> segregated with affected status. Sanger sequencing confirmed this variant in these patients and the proband’s son (GeneDx, Gaithersburg, Maryland, USA).</p>
              </sec>
            </sec>
            <sec id="s3">
              <title>Results</title>
              <sec id="s3a">
                <title>Clinical manifestations of disease</title>
                <p>Four affected patients in three successive generations were studied (<xref ref-type="fig" rid="F1">figure 1A</xref>). The proband presented at 16 years of age with cough, wheezing and chest pain. She was diagnosed with hypersensitivity pneumonitis, unresponsive to corticosteroid therapy. Dyspnoea on exertion developed at 18 years of age. At 20 years of age, nephrolithiasis was detected, and a CT scan revealed cystic lung lesions. She was referred to the NIH Clinical Center with a presumptive diagnosis of lymphangioleiomyomatosis (LAM) at 21 years of age; lung function testing revealed restriction and impaired diffusion capacity. Rheumatoid factor, antimyeloperoxidase antibody, antinuclear antigen, sedimentation rate and C-reactive protein were normal. Serum cystatin-C and beta-2 microglobulin were mildly elevated. Blood urea nitrogen, serum creatinine, urinalysis and 24 hours creatinine clearance were normal.</p>
                <fig id="F1" orientation="portrait" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>Pedigree indicates ages of onset of disease and the relationship between the proband (small black arrow), three affected relatives and four unaffected relatives (mother, aunt and two cousins) (A). Initial high-resolution chest CT scan of the proband and (B) shows multiple bilateral cystic lung lesions. Baseline high-resolution CT scan images demonstrate several small cystic pulmonary lesions (C) and a subpleural lung nodule (open black arrow) (D) in the proband’s asymptomatic father. A necrotic right kidney mass (open white arrow) is found by abdominal CT scan in the proband’s father (E). Lung biopsy of the proband shows reactive lymphoid follicles (solid black arrows) in a predominantly peribronchovascular distribution (F) (H&amp;E, 4× magnification). Carcinoid tumour (G) in a resected right lower lobe nodule and neuroendocrine hyperplasia with positive immunoreactivity for synaptophysin (brown) in lung tissue (H) (10× magnification) are present in the proband’s father, who was also diagnosed with clear cell renal carcinoma (I) (H&amp;E, 10× magnification).</p>
                  </caption>
                  <graphic xlink:href="jmedgenet-2018-105560f01"/>
                </fig>
                <p>The sister had hearing loss due to bacterial meningitis at 2 years of age and bilateral recurrent neuromyelitis optica starting at age 6. She was evaluated at the NIH Clinical Center at 26 years of age with dyspnoea on exertion and a presumptive diagnosis of LAM. Chest CT scan showed lung cysts. Her baseline evaluation showed restriction and severely reduced diffusion capacity. Elevated serum antimyeloperoxidase antibody, cystatin-C and beta-2 microglobulin levels were measured. Urine sediment showed 26 red blood cells/μL (normal &lt;15) without casts. Rheumatoid factor, antinuclear antigen, sedimentation rate, C-reactive protein, blood urea nitrogen, serum creatinine, urine protein and 24 hours creatinine clearance were normal.</p>
                <p>The proband’s 56-year-old father was asymptomatic. Given his daughters’ lung disease, an inherited disorder was considered, and he was carefully phenotyped to assign affected/unaffected status. His evaluation revealed normal lung volumes, but mildly reduced diffusion capacity. Antimyeloperoxidase antibody, antinuclear antigen, sedimentation rate, C-reactive protein, urinalysis and creatinine clearance were within normal limits. Rheumatoid factor, serum cystatin C and serum beta-2 microglobulin were mildly increased.</p>
                <p>The proband’s son was not part of the original NIH evaluation. He presented with intermittent severe coughing paroxysms throughout childhood following respiratory syncytial virus infection at 1 year of age. At 7 years of age, chest CT revealed diffuse tiny lung nodules with a ‘tree-in-bud’ appearance and a small lung cyst. He was confirmed to have the familial <italic>COPA</italic> gene variant and was subsequently evaluated at the NIH Clinical Center. Lung function testing revealed mildly reduced diffusion capacity. Serologies were normal. Serum cystatin C and beta-2 microglobulin were slightly elevated. Urine was negative for protein, red blood cells and casts.</p>
              </sec>
              <sec id="s3b">
                <title>Imaging findings</title>
                <p>Chest CT scans were performed during the NIH Clinical Center evaluations. The proband and sister showed a diffuse interstitial infiltrative process and scattered cystic lesions not characteristic of LAM (<xref ref-type="fig" rid="F1">figure 1B</xref>). Other imaging studies failed to demonstrate any of the extrapulmonary manifestations of LAM. The proband’s renal ultrasound revealed a right renal cyst. Chest CT scans of the asymptomatic father demonstrated discrete cystic lung lesions and several lung nodules suspicious for malignancy (<xref ref-type="fig" rid="F1">figure 1C and D</xref>). The proband’s son’s CT scan at 7 years of age showed a diffuse interstitial pattern and a lung cyst. A necrotic right kidney lesion was interpreted as an incidental finding in the proband’s father (<xref ref-type="fig" rid="F1">figure 1E</xref>).</p>
              </sec>
              <sec id="s3c">
                <title>Histopathology of lung and kidney tissue</title>
                <p>The proband’s lung biopsy showed findings consistent with follicular bronchiolitis. Numerous reactive lymphoid follicles were localised within peribronchovascular and subpleural regions (<xref ref-type="fig" rid="F1">figure 1F</xref>). Emphysema and collections of foamy histiocytes were present. Alveolar haemorrhage was not found in the histological sections.</p>
                <p>The father underwent lung biopsy and lung nodule resection. Pathology showed respiratory bronchiolitis, diffuse lymphoid aggregates, emphysema, neuroendocrine hyperplasia and a carcinoid tumour (<xref ref-type="fig" rid="F1">figure 1G and H</xref>). He also underwent a partial nephrectomy. Histopathology revealed clear cell renal carcinoma (<xref ref-type="fig" rid="F1">figure 1I</xref>). Examination of surrounding non-malignant renal tissue did not demonstrate glomerular disease.</p>
              </sec>
              <sec id="s3d">
                <title>Genetic testing</title>
                <p>Agnostic exome sequencing of the proband, sister and both parents identified a heterozygous variant (c.698 G&gt;A, p.Arg233His) in <italic>COPA</italic> in the father and two offspring; this was Clinical Laboratory Improvement Amendments confirmed by Sanger sequencing. Targeted analysis of DNA from the son revealed the same heterozygous variant in <italic>COPA</italic>. Sanger sequencing for this variant was negative in three unaffected relatives (an aunt and two first cousins).</p>
              </sec>
              <sec id="s3e">
                <title>Longitudinal clinical evaluations</title>
                <p>The adult patients underwent serial evaluations over 11 years at the NIH Clinical Center. The proband’s dyspnoea slowly progressed and hypoxaemia developed at 23 years of age. Longitudinal data showed gradual decline of lung function. Chest CT scans showed progression in the appearance of innumerable small lung cysts, onset of fibrosis, lung nodule development and progressive multiple mediastinal lymph node enlargement. Abdominal imaging revealed increased size and number of renal cysts. Avascular necrosis of her femur and tibia were diagnosed at 28 years of age. Rheumatoid arthritis manifested at 29 years of age. C-reactive protein and rheumatoid factor increased to 5 mg/mL (normal 0–4.99 mg/L) and 98 IU/mL (normal &lt;20 IU/mL), respectively; antinuclear antibody remained negative. Acute pyelonephritis occurred at 32 years of age.</p>
                <p>The older sister has remained clinically stable, but lung function tests have demonstrated onset of airflow obstruction, and chest imaging revealed diffuse bronchial wall thickening and a new small lung nodule. Neuromyelitis optica with severe visual deficit was unchanged in the sister.</p>
                <p>The father, who was initially asymptomatic, developed intermittent cough. Serial pulmonary function testing demonstrated gradual development of lung restriction with stable diffusion capacity. Chest CT scans showed innumerable punctate lung cysts, multiple pulmonary nodules and diffuse bronchial wall thickening. Abdominal MRI detected hepatic cysts.</p>
              </sec>
            </sec>
            <sec id="s4">
              <title>Discussion</title>
              <p>Previous cases affected by Copa syndrome provided the initial insights into the phenotypic pleiotropy of this rare autosomal dominant disorder (<xref rid="T1" ref-type="table">table 1</xref>).<xref rid="R1" ref-type="bibr">1 4 7 8 17</xref> The current kindred contains individuals with some typical features of the disease, including lung cysts, follicular bronchiolitis, interstitial lung disease, neuroendocrine cell hyperplasia, positive autoimmune serologies and arthritis (<xref rid="T1" ref-type="table">table 1</xref>). Avascular necrosis, which was reported in another patient with Copa syndrome, also developed in the proband.<xref rid="R1" ref-type="bibr">1</xref> However, our cohort did not have alveolar haemorrhage or nephritis, which were major elements of previously reported Copa syndrome cases.<xref rid="R1" ref-type="bibr">1 2</xref>
</p>
              <table-wrap id="T1" orientation="portrait" position="float">
                <label>Table 1</label>
                <caption>
                  <p>Clinical manifestations in patients with <italic>COPA</italic> variants</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <thead>
                    <tr>
                      <td valign="bottom" align="left" rowspan="1" colspan="1"><italic>COPA</italic> variant</td>
                      <td valign="bottom" align="left" rowspan="1" colspan="1">Affected kindreds (patients)</td>
                      <td valign="bottom" align="left" rowspan="1" colspan="1">Ethnicity/ <break/>nationality</td>
                      <td valign="bottom" align="left" rowspan="1" colspan="1">Lung</td>
                      <td valign="bottom" align="left" rowspan="1" colspan="1">Kidney</td>
                      <td valign="bottom" align="left" rowspan="1" colspan="1">Rheumatology/ <break/>autoimmune</td>
                      <td valign="bottom" align="left" rowspan="1" colspan="1">Other</td>
                      <td valign="bottom" align="left" rowspan="1" colspan="1">References</td>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td valign="top" align="left" rowspan="1" colspan="1">p.Arg233His</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1 (4)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">White</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">FB, ILD, cysts, carcinoid tumour</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Clear cell carcinoma</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Arthritis, AVN, neuromyelitis optica</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Liver/renal cysts, nephrolithiasis, pyelonephritis meningitis, RSV infection</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">This report</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" rowspan="1" colspan="1">p.Arg233His</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">3 (9)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">White, Asian</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">FB, ILD, AH, cysts</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Glomerulonephritis</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Arthritis, AVN, thyroid disease</td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1">Watkin <italic>et  al</italic>,  <break/>Volpi <italic>et al</italic>
<xref rid="R1" ref-type="bibr">1 17</xref>
</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" rowspan="1" colspan="1">p.Asp243Gly</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1 (3)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">White</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">ILD, AH</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Glomerulonephritis, tubular disease</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Arthritis</td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1">Watkin <italic>et al</italic>
<xref rid="R1" ref-type="bibr">1</xref>
</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" rowspan="1" colspan="1">p.Glu241Lys</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">2 (8)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">White, Icelandic</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">FB, ILD, AH, cysts, neuroendocrine cell hyperplasia</td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1">Arthritis</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Recurrent respiratory infections</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Watkin <italic>et al</italic>, Jenson <italic>et al</italic>
<xref rid="R1" ref-type="bibr">1 4</xref>
</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" rowspan="1" colspan="1">p.Lys230Asn</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1 (5)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">White</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">ILD, AH</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Glomerulonephritis</td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1">Dyskinesia</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Watkin <italic>et al</italic>
<xref rid="R1" ref-type="bibr">1</xref>
</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" rowspan="1" colspan="1">p.Trp240Arg</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1 (1)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">African American</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">ILD, AH?, cysts</td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1">Arthritis</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Failure to thrive</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Noorelahi <italic>et al</italic>
<xref rid="R7" ref-type="bibr">7</xref>
</td>
                    </tr>
                    <tr>
                      <td valign="top" align="left" rowspan="1" colspan="1">p.Asp243Asn</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">1 (1)</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">NR</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">ILD, inflammation, aspiration</td>
                      <td valign="top" align="left" rowspan="1" colspan="1"/>
                      <td valign="top" align="left" rowspan="1" colspan="1">Arthritis, MAS</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">GORD</td>
                      <td valign="top" align="left" rowspan="1" colspan="1">Brennan <italic>et al</italic>
<xref rid="R8" ref-type="bibr">8</xref>
</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="tblfn1">
                    <p>AH, alveolar haemorrhage; AVN, avascular necrosis; FB, follicular bronchitis; GORD, gastro-oesophageal reflux disease; ILD, interstitial lung disease; MAS, macrophage activation syndrome; NR, not reported; RSV, respiratory syncytial virus.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>The presented kindred exhibited some new/atypical manifestations (<xref rid="T1" ref-type="table">table 1</xref>). One affected patient had severe vision loss due to neuromyelitis optica, an autoimmune disorder associated with autoantibodies against aquaporin-4.<xref rid="R18" ref-type="bibr">18</xref> Extrapulmonary cysts in the liver and kidney, nephrolithiasis, infection (ie, acute pyelonephritis, meningitis, respiratory syncytial virus) and malignancies (ie, carcinoid tumour, renal cell carcinoma) were diagnosed in at least one affected patient; these have not been reported in patients with Copa syndrome. Cancers are known to occur in patients with various autoimmune disorders.<xref rid="R19" ref-type="bibr">19 20</xref> It is unclear whether these atypical manifestations in this family are caused by or merely associated with the <italic>COPA</italic> variant.</p>
              <p>An interesting feature of this kindred is the progressively earlier age of onset of lung disease in three consecutive generations. This phenomenon has not been reported in Copa syndrome. Symptoms first manifested in the proband at 16 years of age. Her father was asymptomatic at 56 years of age, and her son presented with symptoms at 1 year of age. A kindred with a different <italic>COPA</italic> variant includes a 32-year-old female proband and her two affected children.<xref rid="R4" ref-type="bibr">4</xref> Notably, these three patients with Copa syndrome were diagnosed with follicular bronchiolitis, and their two-generation pedigree also displayed progressively more severe disease with consecutive generations. The biological basis of this phenomenon in an autosomal dominant disorder with a missense variant is unclear. It may be attributed, at least in part, to a high index of suspicion of disease and evaluation of less severely affected relatives. Technological advances with each generation could also facilitate diagnostic capabilities.</p>
              <p>Six missense variants mapping to amino acid residues 230–243 in the WD40 region in <italic>COPA</italic> have been reported in patients of various ethnicities (<xref rid="T1" ref-type="table">table 1</xref>). Pathogenic <italic>COPA</italic> variants are associated with a defect in protein binding and retrograde protein trafficking from the Golgi to the ER.<xref rid="R1" ref-type="bibr">1</xref> Analysis of tissue and cells from patients with Copa syndrome demonstrate increased ER stress, impaired autophagy, cytokine upregulation and type I interferon pathway activation.<xref rid="R1" ref-type="bibr">1 17</xref> It has not been determined how cellular dysfunction in Copa syndrome contributes to disease pathogenesis.</p>
              <p>Thirty-two individuals with Copa syndrome, including four patients in this family, are reported, and it is unclear whether there is a genotype–phenotype association.<xref rid="R1" ref-type="bibr">1 4 7 8 17</xref> An Arg233His variant was found in four kindreds with 13 affected patients. Longitudinal analysis for our patients demonstrated slowly progressive cystic lung disease and follicular bronchiolitis. In contrast, follicular bronchiolitis in a 32-year-old woman and her 11-year-old son with a Glu241Lys variant progressed, and they received lung transplants.<xref rid="R4" ref-type="bibr">4</xref> Although the Glu241Lys variant is associated with severe lung disease, it has not been reported in patients with Copa syndrome and kidney disease.</p>
              <p>In conclusion, this family with Copa syndrome includes four affected individuals who are heterozygous for a missense <italic>COPA</italic> variant. This family has manifestations not reported in other patients with Copa syndrome, including neuromyelitis optica, extrapulmonary cysts and renal and neuroendocrine malignancies. Furthermore, the slow progression of follicular bronchitis differs from the more rapidly progressive disease observed in another kindred with a different <italic>COPA</italic> variant, which suggests that there may be variable expression associated with Copa syndrome. Overall, the identification of unreported clinical features in this family with Copa syndrome provides new insights into pathogenic mechanisms and hints that the phenotypic spectrum of this disorder is not yet fully defined.</p>
              <supplementary-material content-type="local-data" id="SP1">
                <object-id pub-id-type="doi">10.1136/jmedgenet-2018-105560.supp1</object-id>
                <label>Supplementary data</label>
                <p>
                  <inline-supplementary-material id="ss1" xlink:href="jmedgenet-2018-105560supp001.pdf" mimetype="application" mime-subtype="pdf" content-type="local-data"/>
                </p>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>The authors thank our patients for their participation in our studies.</p>
            </ack>
            <fn-group>
              <fn fn-type="other">
                <p>BRG and JM contributed equally.</p>
              </fn>
              <fn fn-type="other">
                <p>AMT-DS and TCM contributed equally.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Contributors:</bold> All authors contributed to the acquisition, analysis or interpretation of data, revised the manuscript critically for important intellectual content and approved the version to be published. AMT-DS, TCM, WAG, BRG and JM contributed to the conception of this work. AMT-DS, TCM, BRG and JM drafted the manuscript and are responsible for the overall content as guarantor(s).</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Funding:</bold> This research was supported by the Intramural Research Programs of the National Heart, Lung and Blood Institute, the Office of the Director, the National Cancer Institute and the National Human Genome Research Institute, National Institutes of Health.</p>
              </fn>
              <fn fn-type="COI-statement">
                <p><bold>Competing interests:</bold> None declared.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Patient consent:</bold> Obtained.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Ethics approval:</bold> National Heart, Lung, and Blood Institute or National Human Genome Research Institute.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watkin</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Jessen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wiszniewski</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Vece</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Jan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sha</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Thamsen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Santos-Cortez</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gambin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Forbes</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Law</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Stray-Pedersen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Mace</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>LF</given-names></name>, <name name-style="western"><surname>Nicholas</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Nahmod</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Makedonas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Canter</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Kwok</surname><given-names>PY</given-names></name>, <name name-style="western"><surname>Hicks</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Penney</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jhangiani</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Rosenblum</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Dell</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Waterfield</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Papa</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Muzny</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Zaitlen</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Leal</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Gonzaga-Jauregui</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Boerwinkle</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Eissa</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Gibbs</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Lupski</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Orange</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Shum</surname><given-names>AK</given-names></name></person-group><collab>Baylor-Hopkins Center for Mendelian Genomics</collab>. <article-title>COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis</article-title>. <source>Nat Genet</source><year>2015</year>;<volume>47</volume>:<fpage>654</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3279</pub-id>
<pub-id pub-id-type="pmid">25894502</pub-id></mixed-citation>
              </ref>
              <ref id="R2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsui</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Estrada</surname><given-names>OA</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Law</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Elicker</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Dell</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Gudmundsson</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hansdottir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Helfgott</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Volpi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gattorno</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Waterfield</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Ley</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Shum</surname><given-names>AK</given-names></name></person-group><article-title>Analysis of pulmonary features and treatment approaches in the COPA syndrome</article-title>. <source>ERJ Open Res</source><year>2018</year>;<volume>4</volume>:<fpage>2018</fpage><pub-id pub-id-type="doi">10.1183/23120541.00017-2018</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vece</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Watkin</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Nicholas</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Canter</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Braun</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Guillerman</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Eldin</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Bertolet</surname><given-names>G</given-names></name>, <name name-style="western"><surname>McKinley</surname><given-names>S</given-names></name>, <name name-style="western"><surname>de Guzman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Forbes</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chinn</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Orange</surname><given-names>JS</given-names></name></person-group><article-title>Copa syndrome: a novel autosomal dominant immune dysregulatory disease</article-title>. <source>J Clin Immunol</source><year>2016</year>;<volume>36</volume>:<fpage>377</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1007/s10875-016-0271-8</pub-id>
<pub-id pub-id-type="pmid">27048656</pub-id></mixed-citation>
              </ref>
              <ref id="R4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jensson</surname><given-names>BO</given-names></name>, <name name-style="western"><surname>Hansdottir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Arnadottir</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Sulem</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kristjansson</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Oddsson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Benonisdottir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jonsson</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Helgason</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Saemundsdottir</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Magnusson</surname><given-names>OT</given-names></name>, <name name-style="western"><surname>Masson</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Thorisson</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Jonasdottir</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jonasdottir</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sigurdsson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jonsdottir</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Petursdottir</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Kristinsson</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Gudbjartsson</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Thorsteinsdottir</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Arngrimsson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Sulem</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gudmundsson</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Stefansson</surname><given-names>K</given-names></name></person-group><article-title>COPA syndrome in an Icelandic family caused by a recurrent missense mutation in <italic>COPA</italic>
</article-title>. <source>BMC Med Genet</source><year>2017</year>;<volume>18</volume>:<fpage>129</fpage><pub-id pub-id-type="doi">10.1186/s12881-017-0490-8</pub-id><pub-id pub-id-type="pmid">29137621</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quek</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>VT</given-names></name></person-group><article-title>Molecular and cellular studies of the human homolog of the 160-kD alpha-subunit of the coatomer protein complex</article-title>. <source>DNA Cell Biol</source><year>1997</year>;<volume>16</volume>:<fpage>275</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1089/dna.1997.16.275</pub-id>
<pub-id pub-id-type="pmid">9115636</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shima</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Scales</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Kreis</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Pepperkok</surname><given-names>R</given-names></name></person-group><article-title>Segregation of COPI-rich and anterograde-cargo-rich domains in endoplasmic-reticulum-to-Golgi transport complexes</article-title>. <source>Curr Biol</source><year>1999</year>;<volume>9</volume>:<fpage>821</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-9822(99)80365-0</pub-id>
<pub-id pub-id-type="pmid">10469566</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noorelahi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Perez</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Otero</surname><given-names>HJ</given-names></name></person-group><article-title>Imaging findings of Copa syndrome in a 12-year-old boy</article-title>. <source>Pediatr Radiol</source><year>2018</year>;<volume>48</volume>:<fpage>279</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1007/s00247-017-3961-3</pub-id>
<pub-id pub-id-type="pmid">28956095</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brennan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McDougall</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Crow</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Davidson</surname><given-names>J</given-names></name></person-group><article-title>013. COPA syndrome - a new condition to consider when features of polyarthritis and interstitial lung disease are present</article-title>. <source>Rheumatology</source><year>2017</year>;<volume>56</volume><pub-id pub-id-type="doi">10.1093/rheumatology/kex356.059</pub-id></mixed-citation>
              </ref>
              <ref id="R9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gahl</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Tifft</surname><given-names>CJ</given-names></name></person-group><article-title>The NIH Undiagnosed Diseases Program: lessons learned</article-title>. <source>JAMA</source><year>2011</year>;<volume>305</volume>:<fpage>1904</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2011.613</pub-id>
<pub-id pub-id-type="pmid">21558523</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gahl</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Markello</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Toro</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fajardo</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Sincan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gill</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Carlson-Donohoe</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gropman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pierson</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Golas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wolfe</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Groden</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Godfrey</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nehrebecky</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wahl</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Landis</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Madeo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mullikin</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Boerkoel</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Tifft</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>D</given-names></name></person-group><article-title>The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases</article-title>. <source>Genet Med</source><year>2012</year>;<volume>14</volume>:<fpage>51</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/gim.0b013e318232a005</pub-id>
<pub-id pub-id-type="pmid">22237431</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gahl</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Mulvihill</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Toro</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Markello</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Wise</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Ramoni</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Tifft</surname><given-names>CJ</given-names></name></person-group>; <collab>UDN</collab>. <article-title>The NIH Undiagnosed Diseases Program and Network: applications to modern medicine</article-title>. <source>Mol Genet Metab</source><year>2016</year>;<volume>117</volume>:<fpage>393</fpage>–<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymgme.2016.01.007</pub-id>
<pub-id pub-id-type="pmid">26846157</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosas</surname><given-names>IO</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Avila</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Franks</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Travis</surname><given-names>WD</given-names></name>, <name name-style="western"><surname>McCoy</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>May</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Arcos-Burgos</surname><given-names>M</given-names></name>, <name name-style="western"><surname>MacDonald</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Gochuico</surname><given-names>BR</given-names></name></person-group><article-title>Early interstitial lung disease in familial pulmonary fibrosis</article-title>. <source>Am J Respir Crit Care Med</source><year>2007</year>;<volume>176</volume>:<fpage>698</fpage>–<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200702-254OC</pub-id>
<pub-id pub-id-type="pmid">17641157</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gochuico</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Avila</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Novero</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>P</given-names></name>, <name name-style="western"><surname>MacDonald</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Travis</surname><given-names>WD</given-names></name>, <name name-style="western"><surname>Stylianou</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Rosas</surname><given-names>IO</given-names></name></person-group><article-title>Progressive preclinical interstitial lung disease in rheumatoid arthritis</article-title>. <source>Arch Intern Med</source><year>2008</year>;<volume>168</volume>:<fpage>159</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1001/archinternmed.2007.59</pub-id>
<pub-id pub-id-type="pmid">18227362</pub-id></mixed-citation>
              </ref>
              <ref id="R14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avila</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Dwyer</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Moss</surname><given-names>J</given-names></name></person-group><article-title>Lymphangioleiomyomatosis: abdominopelvic CT and US findings</article-title>. <source>Radiology</source><year>2000</year>;<volume>216</volume>:<fpage>147</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1148/radiology.216.1.r00jl42147</pub-id>
<pub-id pub-id-type="pmid">10887241</pub-id></mixed-citation>
              </ref>
              <ref id="R15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moss</surname><given-names>J</given-names></name>, <name name-style="western"><surname>DeCastro</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Patronas</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Taveira-DaSilva</surname><given-names>A</given-names></name></person-group><article-title>Meningiomas in lymphangioleiomyomatosis</article-title>. <source>JAMA</source><year>2001</year>;<volume>286</volume>:<fpage>1879</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1001/jama.286.15.1879</pub-id>
<pub-id pub-id-type="pmid">11597290</pub-id></mixed-citation>
              </ref>
              <ref id="R16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gall</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Valkanas</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bello</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Markello</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bone</surname><given-names>WP</given-names></name>, <name name-style="western"><surname>Brandt</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Brazill</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Carmichael</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Davids</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Diaz-Perez</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Draper</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Elson</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Flynn</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Godfrey</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Groden</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Golas</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Guzman</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kane</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Links</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Maduro</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Malicdan</surname><given-names>MCV</given-names></name>, <name name-style="western"><surname>Malik</surname><given-names>FS</given-names></name>, <name name-style="western"><surname>Nehrebecky</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pemberton</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Schaffer</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Simeonov</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Sincan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Smedley</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Valivullah</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wahl</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Washington</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wolfe</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Gahl</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Tifft</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Toro</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>He</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>PN</given-names></name>, <name name-style="western"><surname>Haendel</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Zhai</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Boerkoel</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>disease</surname><given-names>D</given-names></name></person-group><article-title>Defining disease, diagnosis, and translational medicine within a homeostatic perturbation paradigm: the National Institutes of Health Undiagnosed Diseases Program experience</article-title>. <source>Front Med</source><year>2017</year>;<volume>4</volume>:<fpage>62</fpage><pub-id pub-id-type="doi">10.3389/fmed.2017.00062</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Volpi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tsui</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mariani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pastorino</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Caorsi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Sacco</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Ravelli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shum</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Gattorno</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Picco</surname><given-names>P</given-names></name></person-group><article-title>Type I interferon pathway activation in COPA syndrome</article-title>. <source>Clin Immunol</source><year>2018</year>;<volume>187</volume>:<fpage>33</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2017.10.001</pub-id>
<pub-id pub-id-type="pmid">29030294</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lennon</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Kryzer</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Pittock</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Verkman</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Hinson</surname><given-names>SR</given-names></name></person-group><article-title>IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel</article-title>. <source>J Exp Med</source><year>2005</year>;<volume>202</volume>:<fpage>473</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20050304</pub-id>
<pub-id pub-id-type="pmid">16087714</pub-id></mixed-citation>
              </ref>
              <ref id="R19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hill</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sigurgeirsson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Pukkala</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mellemkjaer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Airio</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Felson</surname><given-names>DT</given-names></name></person-group><article-title>Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study</article-title>. <source>Lancet</source><year>2001</year>;<volume>357</volume>:<fpage>96</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(00)03540-6</pub-id>
<pub-id pub-id-type="pmid">11197446</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernatsky</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Boivin</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Joseph</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Rajan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zoma</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Manzi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ginzler</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Urowitz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gladman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fortin</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Petri</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Edworthy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Barr</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bae</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Sibley</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Isenberg</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rahman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Aranow</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dooley</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Steinsson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nived</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Sturfelt</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Alarcón</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Senécal</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Zummer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hanly</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ensworth</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pope</surname><given-names>J</given-names></name>, <name name-style="western"><surname>El-Gabalawy</surname><given-names>H</given-names></name>, <name name-style="western"><surname>McCarthy</surname><given-names>T</given-names></name>, <name name-style="western"><surname>St Pierre</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ramsey-Goldman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>A</given-names></name></person-group><article-title>An international cohort study of cancer in systemic lupus erythematosus</article-title>. <source>Arthritis Rheum</source><year>2005</year>;<volume>52</volume>:<fpage>1481</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1002/art.21029</pub-id>
<pub-id pub-id-type="pmid">15880596</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
